Clinical trial
A Prospective, Multicenter, Sponsor Initiated, Randomized Controlled Trials to Evaluate the Safety and Efficacy of Genoss® DCB Compared to Sequent® Please in Korean Patients With Coronary Artery In-stent Restenosis (ISR)
NCT04405063 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Sponsor Initiated, Randomized Controlled Trials to Evaluate the Safety and Efficacy of Genoss® DCB Compared to Sequent® Please in Korean Patients With Coronary Artery In-stent Restenosis (ISR)
- Lead sponsor
- Genoss Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- February 28, 2019
- Enrollment
- 82 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.